Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding platelet function through signal transduction.

Alan H Lazarus1, Seng Song, Andrew R Crow

  • 1Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital, The Canadian Blood Services, Toronto, Ontario, Canada. smh.toronto.on.ca

Transfusion Medicine Reviews
|January 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.

Blood advances·2026
Same author

The humoral pathophysiology of immune thrombocytopenia: How close are we to patient-specific disease treatment?

Blood reviews·2026
Same author

Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice.

Journal of immunology (Baltimore, Md. : 1950)·2024
Same author

Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP.

Blood advances·2024
Same author

Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression.

Blood·2023
Same author

TEMRA: the CD8 subset in chronic ITP?

Blood·2023
Same journal

Assessment of CTLA-4, LAG-3, and TIM-3 Expression in Pediatric Patients With β-Thalassemia Major and Their Association With Alloimmunization.

Transfusion medicine reviews·2026
Same journal

A Reply to "Beyond Implementation: The Need for Validation, Equity, and Real-World Accountability in AI for Transfusion Medicine".

Transfusion medicine reviews·2026
Same journal

Beyond Implementation: The Need for Validation, Equity, and Real-World Accountability in AI for Transfusion Medicine.

Transfusion medicine reviews·2026
Same journal

Trust Over Knowledge: Rethinking Donor Iron Supplementation Strategies in Modern Blood Services-Authors' reply.

Transfusion medicine reviews·2026
Same journal

The Effect of Stress Ball and Music on Anxiety, Distress, and Pain Levels During Platelet Apheresis Donation: Randomized Controlled Trial.

Transfusion medicine reviews·2026
Same journal

Therapeutic Plateletpheresis for Thrombocytosis: Critical Analytic Reviews and Original Multicenter Experience.

Transfusion medicine reviews·2026
See all related articles

Understanding platelet transmembrane signaling is key to preventing platelet activation. Inhibiting these signaling pathways offers new strategies for transfusion medicine and improving platelet storage.

Area of Science:

  • Hematology
  • Cellular Biology
  • Biochemistry

Background:

  • Platelet activation involves surface receptor changes, substance secretion, adhesion, aggregation, and thrombus formation.
  • Transmembrane signaling transmits external activation signals to the platelet interior via biochemical cascades.
  • Platelet activation is crucial in hemostasis but also implicated in pathological thrombosis.

Purpose of the Study:

  • To introduce the field of platelet transmembrane signaling.
  • To review signaling mechanisms relevant to transfusion medicine.
  • To explore the potential of inhibiting signaling pathways to prevent platelet activation.

Main Methods:

  • Review of existing literature on platelet activation and transmembrane signaling.
  • Discussion of specific signaling pathways (e.g., glycoprotein Ib-von Willebrand Factor interaction).

Related Experiment Videos

  • Exploration of pharmacological inhibitors and antagonists of signaling molecules.

    • Main Results:

    • Platelet activation is a complex process mediated by transmembrane signaling.
    • Inhibitors of transmembrane signaling molecules can prevent platelet activation.
    • Understanding these mechanisms may help ameliorate the platelet storage lesion.

    Conclusions:

    • Transmembrane signaling is central to platelet activation.
    • Targeting these pathways offers therapeutic potential in preventing unwanted platelet activation.
    • Further research into platelet signaling mechanisms is vital for transfusion medicine applications.